Establishing a Pediatric Reference Range for the 13C-Spirulina Gastric Emptying Breath Test (GEBT)
NCT ID: NCT06004596
Last Updated: 2024-10-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
182 participants
INTERVENTIONAL
2023-03-17
2024-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Participants will blow into test tubes to collect breath samples before and after eating a scrambled egg GEBT meal that contains a small amount of specially grown Spirulina (a blue-green alga used as a dietary supplement) that contains mostly carbon-13 (a non-radioactive kind of carbon atom). Analysis of the amount of 13C in the carbon dioxide in breath before and after eating the GEBT meal can measure how fast food is emptying from the stomach.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Quantitative Ultrasound to Assess Steatotic Liver Disease in Children
NCT06706856
Measurement of in Vivo Mitochondrial Capacity in Infants
NCT03976596
A Registry to Determine the Clinical and Genetic Risk Factors for Torsade De Pointes
NCT02439645
Validation of the STAMP Screening Tool For Pediatric Nutritional Risk
NCT01718769
Normal Liver Stiffness by MR Elastography
NCT03235414
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Breath samples will be collected by children blowing into test tubes before and after eating a 13C-Spirulina GEBT meal. Breath samples will be collected and the test will be administered via telehealth or at one of the children's hospital clinics.
Researchers will analyze results from different age groups to see if there are differences in normal gastric emptying in younger/older children and boys/girls.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Reference Range determination
13C-Spirulina Gastric Emptying Breath Test (GEBT) administered to healthy participants
13C-Spirulina Gastric Emptying Breath Test (GEBT)
Diagnostic test
Biological Variability
13C-Spirulina GEBT administered a second time to subset of participants to determine pediatric biological variability.
13C-Spirulina Gastric Emptying Breath Test (GEBT)
Diagnostic test
13C-Spirulina Gastric Emptying Breath Test (GEBT) - repeat
Diagnostic test - repeat for biological variability deterination
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
13C-Spirulina Gastric Emptying Breath Test (GEBT)
Diagnostic test
13C-Spirulina Gastric Emptying Breath Test (GEBT) - repeat
Diagnostic test - repeat for biological variability deterination
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Healthy and without any significant prior medical history or developmental delays
* Able to eat the test meal and provide breath samples.-
Exclusion Criteria
* Chronic pulmonary disease including moderate/severe reactive airway disease requiring treatment with a daily inhaler
* Type 1 or 2 Diabetes
* Chronic gastrointestinal symptoms or functional gastrointestinal disorders
* Mental retardation or pervasive developmental disorder
* Currently receiving prescription drug therapy that may affect gastric motor function or sensation
* Any over-the-counter or herbal supplements that may affect gastric motor function or sensation
* Allergy to Spirulina, egg, milk, wheat or gluten (unless consuming gluten free crackers with the test meal) or known intolerance to any ingredient in the test meal
7 Years
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical College of Wisconsin
OTHER
Baylor College of Medicine
OTHER
Cairn Diagnostics
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Catherine E Williams, PhD
Role: PRINCIPAL_INVESTIGATOR
Cairn Diagnostics
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cairn Diagnostics
Brentwood, Tennessee, United States
Texas Children's Hospital/Baylor College of Medicine
Houston, Texas, United States
Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CDX-CD-PRO-442
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.